Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.

Revenue
+3.95%
EPS
+34.8%
Free cash flow
−7.09%
Total debt
+15.6%

Quarter to September 2026, against a year earlier

86.21 0.90 +1.05%
Market cap
$9.4B
P/E
22.8×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Dec '25 Mar '26 Jun '26 Sep '26
Revenue

+8 more quarters

3,437.00 3,368.00 3,458.00 3,471.00
Revenue Growth
7.71% 6.31% 6.73% 3.95%
Gross Profit
1,063.00 1,070.00 1,101.00 1,105.00
Operating Income
163.00 182.00 171.00 193.00
EBT
133.00 150.00 137.00 160.00
Income after Tax
101.00 112.00 103.00 123.00
Net Income Common
101.00 107.00 94.00 119.00
EPS (Diluted)
0.85 0.92 0.82 1.12
Shares (Diluted, Weighted)
121.72 116.06 114.39 112.54
Gross Margin
30.93% 31.77% 31.84% 31.84%
EBIT Margin
4.74% 5.40% 4.95% 5.56%
Net Profit Margin
2.94% 3.18% 2.72% 3.43%
EBITDA
244.00 263.00 255.00 279.00
EBIT
163.00 182.00 171.00 193.00

Show all line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 5 Nov 2026